Rite Aid (RAD) Front End Dec. Comps Rose 5.3%

Rite Aid (NYSE: RAD) announced sales results for December.

Monthly SalesFor the four weeks ended Dec. 27, 2014, same store sales increased 5.3 percent over the prior-year period. December front-end same store sales increased 1.7 percent. Pharmacy same store sales, which included an approximate 123 basis points negative impact from new generic introductions, increased 7.3 percent. Prescription count at comparable stores increased 5.1 percent over the prior-year period.

Total drugstore sales for the four-week period increased 4.9 percent to $2.212 billion compared to $2.109 billion for the same period last year. Prescription sales accounted for 64.8 percent of drugstore sales, and third party prescription sales represented 97.6 percent of pharmacy sales.

Year-to-DateSame store sales for the 43-week period ended Dec. 27, 2014 increased 4.3 percent over the prior-year period. Front-end same store sales increased 1.0 percent while pharmacy same store sales increased 5.9 percent. Prescription count at comparable stores increased 3.6 percent over the prior-year period.

Total drugstore sales for the 43 weeks ended Dec. 27, 2014 increased 3.9 percent with sales of $21.762 billion compared to $20.953 billion for the same period last year. Prescription sales represented 68.6 percent of total drugstore sales, and third party prescription sales represented 97.5 percent of pharmacy sales.

You May Also Be Interested In

• Radiopharm reports partial response in RAD204 cancer drug trial
• Vicor Corporation (VICR) PT Lowered to $320 at Needham
• Veraxa Biotech names Christoph Erkel as chief scientific officer